Excision pathways for keratinocyte cancers diagnosed by teledermatology: a retrospective review
J. P. Tirado-Perez
1 * , A. Oakley 2 3 , R. Gansel 2
1
2
3
Abstract
The New Zealand population has one of the highest incidences of skin cancer in the world. Hospital waiting lists for surgical excision of keratinocytic skin cancers (basal cell carcinoma and squamous cell carcinoma) are lengthy, and increasingly, excisions are undertaken in primary care. Teledermatology, in response to general practitioners’ electronic referrals (e-referrals), can improve clinical communication between general practitioners and dermatologists.
The aim of this study was to evaluate an excision pathway for keratinocytic cancers diagnosed by teledermatology.
A retrospective observational descriptive review of a 3-month cohort of primary care e-referrals was undertaken.
Three hundred and fifty eight suspected keratinocytic cancers (KCs) were diagnosed by teledermatology; histology reports confirmed KC in 201 of 267 excisions (75%). The majority (77.2%) were excised by general practitioners an average of 25 days after the dermatologist’s recommendation. The rest were excised by plastic surgeons in private (3.4%) or at a public hospital (19.5%) after an average of 40 or 134 days, respectively.
E-referral pathways are now widely implemented. However, the ideal workflow for skin cancer management is unknown. We have demonstrated in New Zealand that surgery can be undertaken in primary care within a month of a teledermatology diagnosis and excision recommendation.
This study reports prompt excision of KCs by general practitioners after an e-referral and a teledermatology response.
Keywords: basal cell carcinoma, dermatologists, general practitioners, New Zealand, primary care, referrals, Skin cancer, squamous cell carcinoma, workflow.
References
1 Sneyd MJ, Gray A. Expected non melanoma skin (Keratinocytic) cancer incidence in New Zealand for 2018. Wellington: Health Promotion Agency; 2018. Available at https://www.hpa.org.nz/sites/default/files/Expected%20Non%20Melanoma%20Skin%20KC%20incidence%20in%20NZ%20for%202018_FinalReport_777173.pdf
2 Stratigos AJ, Garbe C, Dessinioti C, et al. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention. Eur J Cancer 2020; 128: 60-82.
| Crossref | Google Scholar | PubMed |
3 Gordon LG, Shih S, Watts C, et al. The economics of skin cancer prevention with implications for Australia and New Zealand: where are we now? Public Health Res Pract 2022; 32(1): 31502119.
| Crossref | Google Scholar | PubMed |
4 Na H, Oakley A. Timeliness of diagnosis and treatment of cutaneous melanoma with dermatology, general practice, plastics surgery collaboration – are we meeting standards? J Prim Health Care 2023; 15: 267-73.
| Crossref | Google Scholar | PubMed |
5 McGeoch G, Sycamore M, Shand B, et al. A regional programme to improve skin cancer management. J Prim Health Care 2015; 7: 339-44.
| Crossref | Google Scholar | PubMed |
6 Sunderland M, Teague R, Gale K, et al. E-referrals and teledermatoscopy grading for melanoma: a successful model of care. Australas J Dermatol 2020; 61(2): 147-51 Epub 16 February 2020.
| Crossref | Google Scholar | PubMed |
7 Wen D, Gale K, Martin R. Quality assessment of a large primary GP skin cancer service in Auckland, New Zealand. N Z Med J 2020; 133(1509): 17-27.
| Google Scholar | PubMed |
8 Marwaha SS, Fevrier H, Alexeeff S, et al. Comparative effectiveness study of face-to-face and teledermatology workflows for diagnosing skin cancer. J Am Acad Dermatol 2019; 81(5): 1099-106.
| Crossref | Google Scholar | PubMed |
9 Ferrandiz L, Moreno-Ramirez D, Nieto-Garcia A, et al. Teledermatology-based presurgical management for nonmelanoma skin cancer: a pilot study. Dermatol Surg 2007; 33(9): 1092-8.
| Crossref | Google Scholar | PubMed |
10 Nolan GS, Kiely AL, Totty JP, et al. Incomplete surgical excision of keratinocyte skin cancers: a systematic review and meta‐analysis. Br J Dermatol 2021; 184: 1033-44.
| Crossref | Google Scholar | PubMed |
11 Tirado-Pérez J-P, Oakley A. Surgical excision margins in primary care and plastic surgery for keratinocytic cancers diagnosed via teledermatology: retrospective observational cross-sectional study. iproc 2023; 9: e49466.
| Crossref | Google Scholar |
12 Jones LK, Oakley A. Store-and-forward teledermatology for assessing skin cancer in 2023: literature review. JMIR Dermatol 2023; 6: e43395.
| Crossref | Google Scholar | PubMed |
13 Kim JYS, Kozlow JH, Mittal B, et al. Guidelines of care for the management of cutaneous squamous cell carcinoma. J Am Acad Dermatol 2018; 78(3): 560-78.
| Crossref | Google Scholar |
14 Stratigos AJ, Garbe C, Dessinioti C, et al. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment. Eur J Cancer 2020; 128: 83-102.
| Crossref | Google Scholar | PubMed |
15 Peris K, Fargnoli MC, Garbe C, et al. Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines. Eur J Cancer 2019; 118: 10-34.
| Crossref | Google Scholar | PubMed |
